Last checked at 12 Jul 2021 10:09
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 09 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD |
|
| ||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,870,969 | 1.45% | 240,716 | 0.19% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 227,408 | 0.18% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,949,428 | 1.51% | 474,224 | 0.37% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 226.8900 USD |
| Purchase | 1 | 228.7900 USD |
| Purchase | 2 | 227.5700 USD |
| Purchase | 10 | 227.1100 USD |
| Purchase | 37 | 228.4400 USD |
| Purchase | 100 | 227.4325 USD |
| Purchase | 100 | 227.7993 USD |
| Purchase | 271 | 226.7854 USD |
| Purchase | 310 | 227.8380 USD |
| Purchase | 479 | 228.1634 USD |
| Purchase | 626 | 228.6508 USD |
| Purchase | 781 | 227.7012 USD |
| Purchase | 1,598 | 228.4118 USD |
| Purchase | 2,609 | 228.2710 USD |
| Purchase | 2,668 | 227.7844 USD |
| Purchase | 2,850 | 229.1914 USD |
| Purchase | 3,381 | 228.1045 USD |
| Purchase | 5,612 | 228.3348 USD |
| Purchase | 6,713 | 228.0409 USD |
| Purchase | 10,000 | 227.2757 USD |
| Purchase | 12,964 | 227.8889 USD |
| Purchase | 22,491 | 228.2100 USD |
| Sale | 1 | 226.8900 USD |
| Sale | 5 | 228.7000 USD |
| Sale | 100 | 229.3700 USD |
| Sale | 100 | 228.8000 USD |
| Sale | 100 | 228.7600 USD |
| Sale | 100 | 228.7500 USD |
| Sale | 100 | 227.7993 USD |
| Sale | 100 | 226.8700 USD |
| Sale | 150 | 228.2300 USD |
| Sale | 182 | 227.6759 USD |
| Sale | 200 | 228.6695 USD |
| Sale | 200 | 226.7750 USD |
| Sale | 200 | 226.8200 USD |
| Sale | 200 | 229.1500 USD |
| Sale | 200 | 228.4900 USD |
| Sale | 200 | 228.6000 USD |
| Sale | 229 | 228.2128 USD |
| Sale | 250 | 228.4260 USD |
| Sale | 300 | 226.8533 USD |
| Sale | 300 | 227.2700 USD |
| Sale | 370 | 227.4427 USD |
| Sale | 392 | 227.2227 USD |
| Sale | 400 | 227.2175 USD |
| Sale | 400 | 229.4375 USD |
| Sale | 494 | 228.0398 USD |
| Sale | 550 | 229.2227 USD |
| Sale | 562 | 227.6199 USD |
| Sale | 604 | 227.2405 USD |
| Sale | 679 | 228.4205 USD |
| Sale | 746 | 227.2724 USD |
| Sale | 781 | 227.7012 USD |
| Sale | 857 | 229.3465 USD |
| Sale | 896 | 227.5348 USD |
| Sale | 1,084 | 228.2088 USD |
| Sale | 1,200 | 229.2550 USD |
| Sale | 1,325 | 227.4439 USD |
| Sale | 1,923 | 228.5115 USD |
| Sale | 3,147 | 227.8421 USD |
| Sale | 3,294 | 228.1514 USD |
| Sale | 3,473 | 227.9993 USD |
| Sale | 4,902 | 227.2316 USD |
| Sale | 7,201 | 228.1334 USD |
| Sale | 13,698 | 227.9227 USD |
| Sale | 21,105 | 228.2100 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 12 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
| to which the option |
| |||
| or derivative |
| |||
| relates |
| |||
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210712005323/en/
Copyright Business Wire 2021